Overview
Jessica Taff is a Hematologist and a Hematologist Oncology provider in Forked River, New Jersey. Dr. Taff is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. Her top areas of expertise are Drug-Induced Thrombocytopenia, Iron Deficiency Anemia, Endometrial Cancer, and Endometrial Stromal Sarcoma.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
731 Lacey Rd, Suite 5, Forked River, NJ 08731
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Temple Faculty Practice Plan Inc
Elizabeth Plimack is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Plimack is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. Her top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Abramson Cancer Center Perelman 2nd Floor West
Ronac Mamtani is an Oncologist in Philadelphia, Pennsylvania. Dr. Mamtani is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Mamtani is currently accepting new patients.
Temple Faculty Practice Plan Inc
Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Drug-Induced ThrombocytopeniaDr. Taff isDistinguished. Learn about Drug-Induced Thrombocytopenia.
- Iron Deficiency AnemiaDr. Taff isDistinguished. Learn about Iron Deficiency Anemia.
- Advanced
- AnemiaDr. Taff isAdvanced. Learn about Anemia.
- Breast CancerDr. Taff isAdvanced. Learn about Breast Cancer.
- Cervical CancerDr. Taff isAdvanced. Learn about Cervical Cancer.
- Childhood Iron Deficiency Anemia
- Endometrial CancerDr. Taff isAdvanced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Taff isAdvanced. Learn about Endometrial Stromal Sarcoma.
- Experienced
- Acute Mountain SicknessDr. Taff isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Taff isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Taff isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer